• Users Online: 15
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2020  |  Volume : 5  |  Issue : 2  |  Page : 29-33

The anti-programmed cell death 1 antibody immunotherapy: A paradigm shift in the treatment of nonsmall-cell lung cancer


Department of Medicine, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK

Correspondence Address:
Dr. Victor Chiagoziem Ezenwajiaku
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25 2ZD
UK
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/njct.njct_9_21

Rights and Permissions

With an increasing annual incidence, lung cancer remains the second most common cancer after breast cancer and the most common cause of cancer death worldwide. The distinctive features of its histological subtypes and the multifactorial etiologies ranging from tobacco smoking to genetic predisposition contribute to the associated poor clinical outcomes. Nonsmall-cell lung cancer (NSCLC) which constitutes most of the cases is a molecularly heterogeneous disease associated with poorer prognosis and risk of recurrence. However, this tumoral heterogeneity, which is disadvantageous to traditional chemotherapy, has been shown to be advantageous to immunotherapy in this review. Hence, the application of immune checkpoint inhibitors (ICIs) such as antiprogrammed cell death-1 antibodies has brought a change in thinking in the management of NSCLC, with future combination therapies looking promising in reducing the lung cancer burden. This review focuses on lung cancer background and treatment setbacks, exploring ICIs and antiprogrammed cell death-1 antibody mechanisms, the clinical trials leading to Food and Drug Administration approvals and future advancements.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1739    
    Printed106    
    Emailed0    
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal